NCT00106431 · Interventional trial
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)
Overall registry status Completed
Phase 2
Conditions Cutaneous T-cell Lymphoma
Delaware Valley sites
- University of Pennsylvania Abrahamson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory